Since November 2015, approximately 25% of adults who receive annual seasonal influenza vaccination are immunized in pharmacies or retail health care settings. The growth in vaccine uptake at pharmacies has public health policy makers thinking about the next pandemic. Novel and unanticipated influenza viruses create pandemic potential, and manufacturers hurry to create new vaccines. This creates pressure to provide timely vaccine delivery as efficiently as possible as soon as the FDA allows manufacturers to release the new product.

Consumers' trust in pharmacists is a pivotal factor that may be one of the most important advantages in the event of a flu pandemic.

Read More